Zachary Dolph Hornby

This inventor holds 6 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Boundless Bio, Inc., Ignyta, Inc.. Active years: 2018-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zachary Dolph Hornby. Retrieved from https://idiyas.com/inventor/zachary-dolph-hornby

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 6 (Patent Applications = 2)

% Patents Active = 83.3

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 6.1

ph-index = 3

Forward Citations = 16(Granted Patents)

Company Filing History:

Years Active: 2018-2025

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12246017 - Replication stress pathway agent compositions and methods for treating cancer (2025-03-11),

2. 11642345 - Replication stress pathway agent compositions and methods for treating cancer (2023-05-09),

3. 11547711 - Replication stress pathway agent compositions and methods for treating cancer (2023-01-10),

4. 10869864 - Combinations for the treatment of cancer (2020-12-22),

5. 10357490 - Combinations for the treatment of neuroblastoma (2019-07-23),

6. 10085979 - Combinations for the treatment of neuroblastoma (2018-10-02),

Title: Zachary Dolph Hornby: Innovator in Cancer Treatment

Introduction

Zachary Dolph Hornby is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of cancer treatment, holding a total of 6 patents. His innovative work focuses on addressing challenges in treating specific types of cancer.

Latest Patents

Hornby's latest patents include compositions and methods for treating cancer, particularly targeting extrachromosomal DNA-positive (ecDNA-positive) or therapeutically resistant cancers. These methods involve administering a therapeutically effective amount of a replication stress (RS) pathway agent, either alone or in combination with a targeted therapeutic. This groundbreaking approach aims to improve treatment outcomes for patients facing difficult-to-treat cancers.

Career Highlights

Throughout his career, Hornby has worked with notable companies such as Ignyta, Inc. and Boundless Bio, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in cancer therapies.

Collaborations

Hornby has collaborated with esteemed colleagues, including Gang Li and Christian Andreus Hassig. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of cancer research.

Conclusion

Zachary Dolph Hornby is a dedicated inventor whose work in cancer treatment is paving the way for new therapeutic strategies. His innovative patents and collaborations highlight his commitment to improving patient outcomes in the fight against cancer.

Profile summary based on public USPTO records.